The growth of Viagra and its influence on the pharmaceutical landscape presents a intricate question for investors. While the first sales data were impressive, the exclusivity has expired, leading to a wave of generic alternatives that are chipping away at profit. In addition, the sector is facing challenges related to aging trends and evolving … Read More